RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 to support the growth of human leukemic cells in both monolayer and suspension cultures.
RPMI-1640 medium is a versatile solution with numerous applications for a wide variety of mammalian cell lines, including Jurkat cells, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.
This formulation includes L-Glutamine.
| Size: | Cat Number: |
|---|---|
| 100 ml | LM-R1640/100 |
| 500 ml | LM-R1640/500 |
Safety Data Sheets are also available in other languages. Please contact us if needed.
Pyruvate is the final product of the glycolysis pathway, where glucose is converted into pyruvate with the production of ATP. Sodium pyruvate at 100mM (11g/L)…
HEPES is used in many media because it has more buffering capacity than sodium bicarbonate at physiological pH (7.2 – 7.4) at 37°C. Sodium bicarbonate…
